Ignite Creation Date:
2025-12-25 @ 3:45 AM
Ignite Modification Date:
2025-12-26 @ 2:32 AM
Study NCT ID:
NCT05993702
Status:
UNKNOWN
Last Update Posted:
2023-08-15
First Post:
2023-08-07
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
TAS-102 in Combination With Regorafenib or Fruquintinib for Third-line and Above Advanced Colorectal Cancer
Sponsor:
China Medical University, China
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-09-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-06-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-06-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-08-07
First Submit QC Date:
None
Study First Post Date:
2023-08-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-07
Last Update Post Date:
2023-08-15
Last Update Post Date Type:
ACTUAL